190 related articles for article (PubMed ID: 8213507)
1. Effects of sublingual nitroglycerin on the gas exchange response to exercise in stable angina pectoris.
Sullivan M; Myers J; Buchanan N; Froelicher V
Am J Cardiol; 1993 Oct; 72(11):767-9. PubMed ID: 8213507
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
[TBL] [Abstract][Full Text] [Related]
3. A comparison of buccal nitroglycerin and sublingual nitroglycerin in the prophylaxis and treatment of exertional (situation-provoked) angina pectoris.
Bray CL; Jain S; Faragher EB; Myers A; Myers P; MacIntyre P; Rae A; Goldman M; Alcorn M
Eur Heart J; 1991 May; 12 Suppl A():16-20. PubMed ID: 1908385
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris.
Grasso S; Pesciatini F; Ugolini C; Lepore R; Cerri B
Int J Clin Pharmacol Res; 1988; 8(2):131-7. PubMed ID: 3132428
[TBL] [Abstract][Full Text] [Related]
6. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.
Sullivan M; Savvides M; Abouantoun S; Madsen EB; Froelicher V
J Am Coll Cardiol; 1985 May; 5(5):1220-3. PubMed ID: 3921585
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
Karlson BW; Henning R
Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris.
Taylor SH; Lee P; Jackson N; Cocco G
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S46-9. PubMed ID: 16296709
[TBL] [Abstract][Full Text] [Related]
9. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M
Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
Hayata N; Araki H; Nakamura M
Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
[TBL] [Abstract][Full Text] [Related]
11. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
12. The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study.
Nyberg G
Eur Heart J; 1985 Jul; 6(7):625-30. PubMed ID: 3930248
[TBL] [Abstract][Full Text] [Related]
13. Nitroglycerin lingual spray: clinical efficacy and dose-response relation.
Parker JO; Vankoughnett KA; Farrell B
Am J Cardiol; 1986 Jan; 57(1):1-5. PubMed ID: 3079939
[TBL] [Abstract][Full Text] [Related]
14. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1996 Feb; 93(4):691-6. PubMed ID: 8640997
[TBL] [Abstract][Full Text] [Related]
15. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
17. Nitroglycerin in chronic stable angina pectoris.
Reichek N
Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
19. Nitroglycerin prophylaxis in angina pectoris. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity.
Davidov ME; Green AM
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2473-7. PubMed ID: 6775301
[TBL] [Abstract][Full Text] [Related]
20. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
